The COVID Vaccine That Could Have Ended the Pandemic—And Stopped a Looming "Pandemic of Cancer." The FDA Blocked It. In a stunning account, Dr. Patrick Soon-Shiong reveals the story of the vaccine that was—a true sterilizing shot designed not just to reduce symptoms, but to eliminate the COVID-19 virus from the body entirely. While "Operation Warp Speed" championed antibody-based vaccines, Dr. Soon-Shiong's "BioStrike/BioShield" took a different path. It was engineered to activate T-cells and Natural Killer cells—the body's elite forces for hunting and destroying viruses. His vaccine was the only candidate in a key primate trial that successfully cleared the virus. It promised not just temporary protection, but long-term immunity that could prevent transmission and stop the virus in its tracks. Yet, when he applied to the FDA for a Phase II trial to deploy it as a crucial booster, he was met with a wall of silence and refusal. At the same time, the manufacturing ecosystem was entirely consumed by the major players, leaving no resources for this superior alternative. Dr. Soon-Shiong issues a dire warning rooted in science: COVID-19 is a systemic vascular virus. When it lingers, it causes chronic inflammation. This inflammation, he states, has a "sad, sad chance" of triggering a looming global pandemic of cancer with a 5-10 year latency. The world was given a tool to reduce immediate mortality. But it was denied the tool that could have cleared the virus, potentially prevented long COVID, and averted a future cancer crisis. This is not just a story of a missed opportunity; it's a warning we must now heed.

Well said. A good explanation. Simple but profound. Our NK snd T cells have a highly specialized receptor on their surface called IL15. Ankitiva is a protein we have manufactured that is given as a subcutaneous injection and binds to this IL 15 receptor on the surface of these cancer killing cells, and when this happens these protective and cancer killing NK and T cells expand in huge numbers and become activated. That’s the Bioshield. That’s what is needed to kill cancer and to drive what we call Memory T cells. And we measure the levels in your body of these NK and T cells by a simple blood test called ALC. The Absolute Lymphocyte Count. The ALC levels have been hidden in plain sight. So ask your doctor what are your ALC levels ..” What is my ALC” should be a routine question ….and don’t be surprised if your doctor had not looked at it before or know about the term ALC ..It’s not your doctor’s fault because until now, in the history of medicine there was nothing they could prescribe to fix an ALC if it was low for this medical diagnosis called LYMPHOPENIA. We could fix anemia so we routinely looked at hemoglobin levels and oncologists routinely check the Red blood cell levels after chemo therapy. We could fix what we called neutropenia, so oncologists routinely looked at neutrophil levels called ANC ( absolute neutrophil count). So our doctors are very familiar with ANEMIA and NEUTROPENIA all measurable and treatable. But until now we could not fix LYMPHOPENIA as measured by a low ALC below 1000 cells - the most dangerous diagnosis of low NK cells and T cells - so we ignored ALC ( Absolute lymphocyte count) present in the same test, called the CBC. Hope this explanation of all these medical acronyms helps to explain why ALC has been a “ mystery” for so long …,both to our healthcare professionals as well as the patients who need to know. Today it is not just measurable but treatable. Anktiva is today only approved for a small subset of bladder cancer. We have completed our trials that took years to do across 10 different cancers and showed when we increase ALC in patients regardless of tumor types including patients with lung cancer, the results of combining Anktiva changes the course of survival regardless of the cancer type. That makes sense since we were treating the immune system and our NK and T cells kill ALL CANCERS regardless of tumor type. Details of this study has been submitted for peer review. More to come. Education through X! Connecting the dots of a 35 year quest with the epiphany starting from my earliest publication while at UCLA in 1990 that NK cells are the key immune cells to survival and now perhaps even the key to longevity.

🚨 BREAKING — Nearly Half of “COVID-19 Deaths” Were Not Due to COVID-19, New Study Finds 🚫45.3% of "COVID-19 deaths" in Athens, Greece had NO SYMPTOMS — only a positive PCR test ✅Confirmed via clinical adjudication, chart audits & physician interviews 🌎Greece followed the same death coding rules as the U.S. & EU — similar false death inflation likely occurred worldwide ⚠️Confirms a coordinated PSYOP of fear: inflated deaths used to justify lockdowns & mRNA mandates

Imagine your immune system as a tiny medieval town. Your lymphocytes are the knights, the scouts, and the quick-thinking town guards who keep troublemakers from getting past the gates. Dr. Pat Soon-Shiong’s line is basically saying: “Lymphocyte depletion is the floor” means the lowest thing you should tolerate is having too few of these guards. If your lymphocytes drop to a very low level, the immune system is operating on the basement floor of performance. “Functional competence is the ceiling” means the best you can hope for is that your lymphocytes are not only present but lively, skilled, alert, and doing their jobs well. High-performing guards on the top floor. Then he says: “Ask your doctor, what is my ALC?” ALC means Absolute Lymphocyte Count, a number you get on a routine complete blood count (CBC). It tells you how many lymphocytes you have per microliter of blood. Why does this matter? Your ALC is one of the simplest, clearest ways to see if your immune system is struggling, stressed, inflamed, suppressed, or recovering. Low ALC can come from chemotherapy, steroids, infections, chronic inflammation, autoimmune conditions, or even long-term metabolic disease. High or normal doesn’t always guarantee those cells are working well, but too low is always a red flag.

Then it would be wise to cut the red tape. My husband has to start Chemo and radiation Tuesday and go through that before qualifying for your study and if you were to begin with us now you would have documentation connected with Cedar Sinai. Help. piped.video/Oyq6-Z7im3M?si=6PWW…

$qure, $xbi, not expecting VP’s permanent departure 3 days after @WSJEditorials piece smacking @US_FDA last time in July. Worth watching as timeline evolves! Time to give rare disease patients hope and access to innovative medicines. US biotech innovation can’t be stopped!

Dr., what about oncogene driven NSCLC with very low PD-L1?

I have exciting personal news. This Sunday I will be launching a new weekly show ‘Straight To The Point with Catherine Herridge’ This means more investigations and more big interviews that demand accountability. It's a first of its kind collaboration with the LA Times Media Group. Our team retains 100% editorial control and I remain an independent journalist. This partnership acknowledges the media marketplace is changing. It's time to get Straight To The Point.